Abbott Laboratories ($ABT) continues the launch of new products, stock rises

By |January 20th, 2017|Opinions|

Abbott Laboratories ($ABT) announced that it has launched its Proclaim DRG Neurostimulation System in Europe. The system is designed to deliver dorsal root ganglion stimulation to patients with chronic neuropathic pain. The system is magnetic resonance conditional. It is also recharge free and is easy to use as it uses [...]

Premarket Biotech Digest –$VRX moves up, $SGYP gets FDA approval, $OFIX to pay penalty

By |January 20th, 2017|Digest|

Cytori Therapeutics ($CYTX) announced the acquisition of certain assets from Azaya Therapeutics, which is a privately held firm. Under the terms of the deal, Cytori will issue $2 million in Cytori common stock up front. It will also assume nearly $2 million of Azaya’s [...]

Celsion ($CLSN) receives two new patents for ThermoDox

By |January 19th, 2017|Opinions|

Celsion Corporation ($CLSN) reported receiving two new patents for ThermoDox formulation. The company said that one patent has been granted by the United States Patent and Trademark Office, while the other comes from Korea. These patents will help boosting the global coverage of ThermoDox, which is currently in Phase III [...]

Premarket Biotech Digest – $APRI receives approval, $AGN to pay penalty, $TEVA receives FDA nod

By |January 19th, 2017|Digest|

Abbott Laboratories ($ABT) announced that it has launched its Proclaim DRG Neurostimulation System in Europe. The system is designed to deliver dorsal root ganglion stimulation to patients with chronic neuropathic pain. The system is magnetic resonance conditional. It is also recharge free and is [...]

Forward Pharma settles the case with Biogen

By |January 18th, 2017|Opinions|

Forward Pharma A/S ($FWP) announced that it has signed a Settlement and License Agreement with Biogen ($BIIB). Both the companies were engaged in a dispute over a patent covering methods of treating multiple sclerosis (MS) with 480 mg of dimethyl fumarate (DMF), the active ingredient in Biogen's top selling Tecfidera. [...]

Premarket Biotech Digest – $ARRY retains momentum, $MCK to pay penalty, $BIIB announces collaboration

By |January 18th, 2017|Digest|

Celsion Corporation ($CLSN) stock climbed to its intraday high of $0.62 in the Tuesday trading session. The stock eventually closed at $0.510, up 30.77%. The company announced continued data from the fourth cohort of patients in its Phase Ib dose escalating clinical trial (the [...]

Herbalife ($HLF) starts the year with renewed upswing

By |January 17th, 2017|Opinions|

Herbalife ($HLF) stock shows strong movements in its Friday trading sessions. The stock recorded intraday high of $52.20, before closing at $52, up 4.12%. The company stock reacted to the news of the resignation by Federal Trade Commission Chairwoman Edith Ramirez. She had been a vocal opponent of the company’s [...]

Premarket Biotech Digest – $CYTR continues upmove, $FWP signs settlement, $UNH reports results

By |January 17th, 2017|Digest|

Forward Pharma A/S ($FWP) surged in the premarket session as it emerged that it has signed a Settlement and License Agreement with Biogen ($BIIB). Both the companies were engaged in a dispute over a patent covering methods of treating multiple sclerosis (MS) with 480 [...]

Mast Therapeutics Surges on Merger with Savara

By |January 16th, 2017|Opinions|

Mast Therapeutics Inc. ($MSTX) stock gained over 57% this year so far as the company announced its merger with specialty Pharmaceuticals company Savara Inc. The gain this year has helped the stock in recouping some of the losses it had incurred in the previous year. Pursuant to the merger, the [...]

Premarket Biotech Digest – My New Swing Trading Group Accepting Members, $SGYP surges, $HLF reprieved, $AXON rating

By |January 16th, 2017|Digest|

== Make Money Swing Trading - Join My New Trading Group - Email drkkde@gmail.com Now == == Synergy Pharmaceuticals Inc. ($SGYP) stock continues its strong upward movement in the new year. The company stock has gained 67% in the past one year while its [...]

Illumina ($ILMN) provides strong forecast, stock upbeat

By |January 13th, 2017|Opinions|

Illumina Inc. ($ILMN) has shown encouraging stock price movement in the new year. Its stock is 27% up on year to date basis, thanks to positive news from the company. Illumina recently announced the launch of a new DNA sequencer with new architecture. The company said that the new architecture [...]

Premarket Biotech Digest – $MSTX acquires Savara, $LLY receives positive ruling, $SHPG settles case

By |January 13th, 2017|Digest|

Mast Therapeutics Inc. ($MSTX) stock gained over 60% in the past 5 days as the company announced its merger with specialty Pharmaceuticals company Savara Inc. Under the terms of the agreement, stockholders of Savara would become the majority owners of Mast, and the operations [...]

MiMedx Group announces fourth quarter results, provides guidance

By |January 12th, 2017|Opinions|

MiMedx Group ($MDXG) reported upbeat results for its fourth quarter recently. The company also provided encouraging forecast for FY 2017. Its fourth quarter revenue surged 38 percent to touch $71.6 million figure. The total revenue for the FY 2016 stood at $246.8 million, up 32% on year over year basis. [...]

Premarket Biotech Digest – $BIOC signs new contract, $ISRG receives neutral rating, $BSX to launch new product

By |January 12th, 2017|Digest|

Histogenics ($HSGX) stock jumped over 54% in its pre-market session. The stock responded to the news of positive data from Phase 1 & 2 studies assessing lead product candidate NeoCart for the repair of articular cartilage injuries in the knee. The tests were conducted [...]

Merck announces collaboration with Eli Lilly for immune-oncology treatments

By |January 11th, 2017|Opinions|

Merck ($MRK) has expanded the scope of its immune-oncology tie up with Eli Lilly ($LLY). The alliance has started a new study for assessing the combination of LARTRUVO (olaratumab) and KEYTRUDA (pembrolizumab) in treatment-experienced patients with advanced/metastatic soft tissue sarcoma (STS). LARTRUVO was approved by the FDA in October 2016, [...]

Premarket Biotech Digest – $ETRM soars, $RHHBY announces acquisition, $RDY launches new products

By |January 11th, 2017|Digest|

EnteroMedics Inc. ($ETRM) stock showed strong moves in its Tuesday trading session as it jumped to its intraday high of $30.41. The stock eventually closed at $27.70, up 56.5% from its previous close. The company recently announced the development of its new treatment called [...]

Merrimack Pharmaceuticals ($MACK) to divest some assets

By |January 10th, 2017|Opinions|

Merrimack Pharmaceuticals ($MACK) announced selling some of its assets to Ipsen ($IPSEY). These assets include pancreatic cancer drug Onivyde. The deal is likely to be valued at nearly $1 billion. Ipsen will pay $575 million at the closing of the deal. It will also pay up to $450 million upon [...]

Premarket Biotech Digest – $ILMN launches DNA sequencer, $GALE receives subpoena, $INCY gets buy rating

By |January 10th, 2017|Digest|

Illumina ($ILMN) announced the launch of a new DNA sequencer with new architecture. The new sent the stock over 11% up in the pre-market session. The company said that the new architecture may lower the costs of decoding human genome considerably. Illumina is of [...]

Bristol-Myers Squibb to collaborate with GeneCentric

By |January 9th, 2017|Opinions|

Bristol-Myers Squibb ($BMY) made several announcements which are likely to have impact on its stock price. The company reported its new research collaboration with cancer diagnostics firm GeneCentric. The collaboration will involve identifying translational biomarkers which may help in designing future trial plan for cancer drug Opdivo. GeneCentric holds a [...]

Premarket Biotech Digest – $IPSEY acquires assets, $CG plans sale, $ATHN receives Overweight rating

By |January 9th, 2017|Digest|

Quotient Ltd. ($QTNT) stock jumped as it announced positive results for its performance evaluation antigen typing study using its automated MosiaQ system. The system is used as the platform for blood grouping and donor disease screening associated with transfusion diagnostics. The study consisted of [...]

s2Member®